Menu
Back to User profile » Dr Qiang Li
Papers published by Dr Qiang Li:
Transtracheal single-point stent fixation in posttracheotomy tracheomalacia under cone-beam computer tomography guidance by transmural suturing with the Berci needle – a perspective on a new tool to avoid stent migration of Dumon stents
Hohenforst-Schmidt W, Linsmeier B, Zarogoulidis P,Freitag L, Darwiche K, Browning R, Turner JF, Huang H, Li Q, Vogl T, Zarogoulidis K, Brachmann J, Rittger H
Therapeutics and Clinical Risk Management 2015, 11:837-850
Published Date: 22 May 2015
Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
Pitsiou G, Zarogoulidis P, Petridis D, Kioumis I, Lampaki S, Organtzis J, Porpodis K, Papaiwannou A, Tsiouda T, Hohenforst-Schmidt W, Kakolyris S, Syrigos K, Huang H, Li Q, Turner JF, Zarogoulidis K
Drug Design, Development and Therapy 2014, 8:1753-1763
Published Date: 7 October 2014
Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
Zarogoulidis P, Kioumis I, Lampaki S, Organtzis J, Porpodis K, Spyratos D, Pitsiou G, Petridis D, Pataka A, Huang H, Li Q, Yarmus L, Hohenforst-Schmidt W, Pezirkianidis N, Zarogoulidis K
Drug Design, Development and Therapy 2014, 8:1065-1072
Published Date: 12 August 2014
“Denervation” of autonomous nervous system in idiopathic pulmonary arterial hypertension by low-dose radiation: a case report with an unexpected outcome
Hohenforst-Schmidt W, Zarogoulidis P, Oezkan F, Mahnkopf C, Grabenbauer G, Kreczy A, Bartunek R, Darwiche K, Freitag L, Li Q, Huang H, Vogl T, LePilvert P, Tsiouda T, Tsakiridis K, Zarogoulidis K, Brachmann J
Therapeutics and Clinical Risk Management 2014, 10:207-215
Published Date: 27 March 2014
Clinical experimentation with aerosol antibiotics: current and future methods of administration [Corrigendum]
Zarogoulidis P, Kioumis I, Porpodis K, Spyratos D, Tsakiridis K, Huang H, Li Q, Turner JF, Browning R, Hohenforst-Schmidt W, Zarogoulidis K
Drug Design, Development and Therapy 2014, 8:121-122
Published Date: 16 January 2014
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
Zarogoulidis K, Boutsikou E, Zarogoulidis P, Darwiche K, Freitag L, Porpodis K, Latsios D, Kontakiotis T, Huang H, Li Q, Hohenforst-Schmidt W, Kipourou M, Turner JF, Spyratos D
OncoTargets and Therapy 2013, 6:1493-1500
Published Date: 22 October 2013
Clinical experimentation with aerosol antibiotics: current and future methods of administration
Zarogoulidis P, Kioumis I, Porpodis K, Spyratos D, Tsakiridis K, Huang H, Li Q, Turner JF, Browning R, Hohenforst-Schmidt W, Zarogoulidis K
Drug Design, Development and Therapy 2013, 7:1115-1134
Published Date: 2 October 2013
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study
Zarogoulidis K, Ziogas E, Boutsikou E, Zarogoulidis P, Darwiche K, Kontakiotis T, Tsakiridis K, Porpodis K, Latsios D, Chatzizisi O, Karapantzos I, Li Q, Kyriazis G
Drug Design, Development and Therapy 2013, 7:611-617
Published Date: 23 July 2013
Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies
Hohenforst-Schmidt W, Zarogoulidis P, Darwiche K, Vogl T, Goldberg EP, Huang H, Simoff M, Li Q, Browning R, Turner FJ, Le Pivert P, Spyratos D, Zarogoulidis K, Celikoglu SI, Celikoglu F, Brachmann J
Drug Design, Development and Therapy 2013, 7:571-583
Published Date: 18 July 2013